Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 26

    1.

    Developing Health Technology Assessment to address health care system needs.

    Velasco Garrido M, Gerhardus A, Røttingen JA, Busse R.

    Health Policy. 2009 Nov 2. [Epub ahead of print]PMID: 19889471 [PubMed - as supplied by publisher]Related articles

    2.

    [In Process Citation]

    Busse R, Zander B, Blümel M.

    Pflege Z. 2009 Oct;62(10):610-1. German. No abstract available. PMID: 19883032 [PubMed - in process]

    3.

    Balancing adoption and affordability of medical devices in Europe.

    Schreyögg J, Bäumler M, Busse R.

    Health Policy. 2009 Oct;92(2-3):218-24. Epub 2009 May 1.PMID: 19410326 [PubMed - in process]Related articles

    4.

    Measuring, monitoring, and managing quality in Germany's hospitals.

    Busse R, Nimptsch U, Mansky T.

    Health Aff (Millwood). 2009 Mar-Apr;28(2):w294-304. Epub 2009 Jan 27.PMID: 19174391 [PubMed - in process]Related articles

    5.

    Effectiveness and cost of atypical versus typical antipsychotic treatment for schizophrenia in routine care.

    Stargardt T, Weinbrenner S, Busse R, Juckel G, Gericke CA.

    J Ment Health Policy Econ. 2008 Jun;11(2):89-97.PMID: 18509216 [PubMed - indexed for MEDLINE]Related articles

    6.

    Variability in healthcare treatment costs amongst nine EU countries - results from the HealthBASKET project.

    Busse R, Schreyögg J, Smith PC.

    Health Econ. 2008 Jan;17(1 Suppl):S1-8. No abstract available. PMID: 18186039 [PubMed - indexed for MEDLINE]Related articles

    7.

    Cross-country comparisons of costs: the use of episode-specific transitive purchasing power parities with standardised cost categories.

    Schreyögg J, Tiemann O, Stargardt T, Busse R.

    Health Econ. 2008 Jan;17(1 Suppl):S95-103.PMID: 18186031 [PubMed - indexed for MEDLINE]Related articles

    8.

    Pricing behaviour of pharmacies after market deregulation for OTC drugs: the case of Germany.

    Stargardt T, Schreyögg J, Busse R.

    Health Policy. 2007 Nov;84(1):30-8. Epub 2007 Jun 5.PMID: 17553587 [PubMed - indexed for MEDLINE]Related articles

    9.

    Strategic purchasing to improve health system performance: key issues and international trends.

    Busse R, Figueras J, Robinson R, Jakubowski E.

    Healthc Pap. 2007;8 Spec No:62-76. No abstract available. PMID: 19096267 [PubMed - indexed for MEDLINE]Related articles

    10.

    Cost accounting to determine prices: how well do prices reflect costs in the German DRG-system?

    Schreyögg J, Tiemann O, Busse R.

    Health Care Manag Sci. 2006 Aug;9(3):269-79.PMID: 17016933 [PubMed - indexed for MEDLINE]Related articles

    11.

    Methods to determine reimbursement rates for diagnosis related groups (DRG): a comparison of nine European countries.

    Schreyögg J, Stargardt T, Tiemann O, Busse R.

    Health Care Manag Sci. 2006 Aug;9(3):215-23.PMID: 17016927 [PubMed - indexed for MEDLINE]Related articles

    12.

    Hospital case payment systems in Europe.

    Busse R, Schreyögg J, Smith PC.

    Health Care Manag Sci. 2006 Aug;9(3):211-3.PMID: 17016926 [PubMed - indexed for MEDLINE]Related articles

    13.

    Hospitalisation costs of cystic fibrosis.

    Schreyögg J, Hollmeyer H, Bluemel M, Staab D, Busse R.

    Pharmacoeconomics. 2006;24(10):999-1009.PMID: 17002482 [PubMed - indexed for MEDLINE]Related articles

    14.

    [Attempt to exclude invasive cardiology services in Poland--rationing, national sovereignty and European Union law]

    Gericke CA, Busse R, Sakowska I, Kuszewski K, Maciag A.

    Przegl Epidemiol. 2006;60(2):323-9. Review. Polish. PMID: 16964685 [PubMed - indexed for MEDLINE]Related articles

    15.

    [The impact of co-payments on patient behavior: evidence from a natural experiment]

    Grabka MM, Schreyögg J, Busse R.

    Med Klin (Munich). 2006 Jun 15;101(6):476-83. German. PMID: 16767571 [PubMed - indexed for MEDLINE]Related articles

    16.

    Regulation of pharmaceutical markets in Germany: improving efficiency and controlling expenditures?

    Busse R, Schreyögg J, Henke KD.

    Int J Health Plann Manage. 2005 Oct-Dec;20(4):329-49.PMID: 16335081 [PubMed - indexed for MEDLINE]Related articles

    17.

    Determining the "Health Benefit Basket" of the Statutory Health Insurance scheme in Germany: methodologies and criteria.

    Busse R, Stargardt T, Schreyögg J.

    Eur J Health Econ. 2005 Dec;Suppl:30-6. Review.PMID: 16270210 [PubMed - indexed for MEDLINE]Related articles

    18.

    Analysing the impact of health-care system change in the EU member states--Germany.

    Wörz M, Busse R.

    Health Econ. 2005 Sep;14(Suppl 1):S133-49. Review.PMID: 16161188 [PubMed - indexed for MEDLINE]Related articles

    19.

    The road to reform.

    Figueras J, Menabde N, Busse R.

    BMJ. 2005 Jul 23;331(7510):170-1. No abstract available. PMID: 16037421 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Health care reform in Germany: patchwork change within established governance structures.

    Altenstetter C, Busse R.

    J Health Polit Policy Law. 2005 Feb-Apr;30(1-2):121-42.PMID: 15943390 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data

    Search details

    » See more...